Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
108
Views
48
CrossRef citations to date
0
Altmetric
Research Article

Current Status and Future of Relapsed Primary Central Nervous System Lymphoma (PCNSL)

Rose Marie Tyson Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA
,
Tali Siegal Hadassah Hebrew University Hospital, Jerusalem, Israel
,
Nancy D. Doolittle Department of Neurosurgery, Oregon Health & Science University, Portland, OR 97239, USA
,
Cynthia Lacy Department of Veteran Affairs Medical Center Portland Division, Portland, OR 97239, USA
,
Dale F. Kraemer Division of Medical Informatics and Outcomes Research, Oregon Health & Science University, Portland, OR 97239, USA
&
Edward A. Neuwelt Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA
Pages 627-633 | Published online: 01 Jul 2009

  • Com, B.W., Marcus, S.M., Topham, A., Hauck, W. and Curran, W.J. (1997) "Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?", Cancer 79, 2409-2413.
  • DeAngelis, L.M. (1999) "Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy", Journal of Neuro. Oncology. 43, 249-257.
  • Abrey, L.E., DeAngelis, L.M. and Yahalom, J. (1998) "Long-term survival in primary CNS lymphoma", Journal Clinical Omology 16(3), 859-863
  • Khalfallah, S., Stamatoullas, A., Fruchart, C., Proust, F., Delangre, T. and Tilly, H. (1996) "Durable remission of a relapsing primary central nervous system lymphoma after autologous bone marrow transplantation", Bone Marrow Transplantation 18, 1021-1023.
  • Blay, J.Y., Conroy, T., Chevreau, C., Thyss, A., Quesnel, N., Houchingue, E., Bouabdallah, R., Coiffier, B., Wagner, J.P., LeMevel, A., Dramais-Marcel, D., Baumelou, E., Chauvin, F. and Biron, P. (1998) "High-dose meyhotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series", Journal of Clinical Oncology 16(3), 864-871.
  • Ervin, T. and Canellos, G.P. (1980) "Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate", Cancer 45, 1556-1557.
  • Soussain, C. Suzan, F., Hoang-Xuan, K., Cassoux, N., Levy, V., Azar, N., Belanger, C., Achour, E., Ribrag, V., Gerber, S., Delattre, J.Y. and Leblond, V (2001) "Results of intensive chemotherapy followed by hematopoeitic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma". Journal of Clinical Oncology 19(3), 742-749.
  • del Giglio, A., Costa, L.J.M., Pinczowski, H., Varella, P.C.S., Luzzi, J.R., Neves, P., Mota, A., Boente, P. and Sampaio, C. (1999) "Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen to relapsed lymphoma patients". Acta Haematol 102, 56-58.
  • Abrey, L.H., Yahalom, J. and DcAngelis, L.M. (2000) "Treatment for primary CNS lymphoma: the next step", Journal of Clinical Oncology 18(17), 3144-1150.
  • Abrey, L.E., Moskowitz, C.H., Mason, W.P., Mason, D., Stewart, P.A., Forsyth, D.M., Caron, L.M. and DeAngelis, L.M. (2001) "A phase II study of intensive methotrexate and cytarabine followed by high dose BEAM chemotherapy with autologous stem cell transplantation (ASCT) in patients with newly diagnosed primary central nervous system lymphoma (PCXSL) [Abstract]", American Society of Clinical Oncology 20(1), 53a.
  • Chon, B., Hochberg, G., Loeffler, J. and Batchelor, T. (2001) "Methotrexate reinduction in patients with relapsed primary central nervous system lymphoma [Abstract]",Neuro-Oncology 3, 356.
  • Herrlinger, U., Schabet, M., Brugger, W., Kortmann, R.D., Kirker, W., Decken, M., Engel, C., Schmeck-Lindenau, H.J., Mergenthaler, H.G., Krauseneck, P. and Benöhr, C. (2002) "German cancer society neuro-oncology working group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma", Annals of Neurology 51, 247-252.
  • Kroll, R.A. and Neuwelt, E.A. (1998) "Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means", Neurosurgery 42(5), 1083-1100.
  • McAlbster, L.D., Doolittle, N.D., Guastadisegni, P., Kraemer, D.F., Lacy, CA., Crossen, J.R. and Neuwelt, E.A. (2000) "Cognitive outcomes and long term follow-up after enhanced chemotherapy delivery for primary central nervous system lymphomas", Neurosurgery 46, 51-61.
  • Doolittle, N.D., Miner, M.E., Hall, W.A., Siegal, T., Hanson, E.J., Osztic, H., McAllister, L.D., Buhalo, J.S., Kraemer, D.F., Fortin, D., Nixon, R., Muldoon, L.L., and Neuwelt, E.A. (2000) "Safety and efficacy of a multi-center study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of malignant brain tumors", Cancer 88, 637-647.
  • Williams, P.C., Henoer, W.D., Roman-Gotdstein, S., Dahlborg, S.A., Brummen, R.D., Tableman, M., Dana, B.W. and Neuwelt, E.A. (1995) "Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms", Neurosurgery 37, 17-28.
  • Doolittle, N.D., Muldoon, L.L., Brummett, R.E., Tyson, R.M., Lacy, C., Bubalo, J.S., Kraemer, D.F., Heinrich, M.C, Henry. J.A. and Neuwelt, E.A. (2001) "Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors", Clinical Cancer Research 7, 493-500.
  • Muldoon, L.L., Pagel, M.A., Kroll, R.A., Brummett, R.E., Doolittle, N.D., Zuhowski, E.G., Egorin, MJ., and Neuwelt, E.A. (2000) "Delayed administration of sodium thiosulfate in animal models reduces platinum toxicity without reduction of antitumor activity", Clinical Cancer Research 6, 309-315.
  • Dooliule, N.A., Tyson, R.M., Lacy, C., Quipotla, J., Bubalo, J.S., Kraemer, D.F., DeLoughery, T.G. and Neuwelt, E.A. (2001) "Potential role of delayed sodium thiosulfate as protectant against severe carboplatin-induced thrombocytopenia in patients with malignant brain tumors [Abstract]", Blaod 98, 37a-38a.
  • Fortin, D., McAllister, L.D., Nesbit, G., Doolittle, N.D., Miner, M., Hanson, E.J. and Neuwelt, E.A. (1999) "Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclo-phosphamide in conjunction with osmotic blood-barrier disruption in the vertebral artery". American Journal of Neuroradiology 20, 1794-1802.
  • Witzig, T.E., White, C.A., Wiseman, G.A., Gordon, L.I., Emmanouilides, C., Raubitsehek, A., Janakiraman, N., Gutheil, J., Schilder, R.J., Spies, S., Silverman, D.H., Parker, H. and Grillo-Lopez, A.J. (1999) "Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20+ B-cell Non-Hodgkins lymphoma". Journal of Clinical Oncology 17(12), 3793-3803.
  • Press, O.W. and Rasey, J. (2000) "Principles of radioimmunotherapy for hematologists and oncologists", Seminars in Oncology 27(6), 62-73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.